[ad_1]
FT.worth it, Texas, May 17, 2021 / PRNewswire /-Pharmacy software solutions company FDS Amplicare and Mutual Drug, a member network with more than 500 independent pharmacies, today announced the launch of Mutual Drug Analytics, a pharmacy software solution for Mutual Drug members.
Mutual Drug Analytics is a dedicated care solution for community pharmacies, designed to change financial and operational performance in the following ways:
- The ability to unleash pharmacy data to convert accurate snapshots into performance
- Drive growth through intelligent analytics and provide easily accessible care opportunities
- Improve patient care by tracking supplementary and missing patient activities, then prioritize outreach to improve medication compliance, etc.
“Every day, independent pharmacists face the challenge of providing high-quality care while taking into account the complex financial reality of unpredictable DIR costs, increased overhead costs, and reduced consumer spending.” Michael Ziegler, Vice President of Strategic Partnerships and Corporate Sales, FDS Amplicare. “The new products we provide in collaboration with Mutual Drug enable pharmacies to use data and analysis to immediately identify opportunities to improve care and services, and most importantly, bring financial success to pharmacies.”
Mutual Drug Analytics is available to members of Mutual Drug pharmacy, which marks the first time that Mutual Drug has cooperated with partner companies to provide customized pharmacy software. Independent pharmacies can easily incorporate Mutual Drug Analytics into their existing daily operations to help drive financial growth and improve patient compliance with medications, thereby reducing DIR costs.
He said: “The pharmacist embodies the selfless care and service that our country needs in this unprecedented period. Regardless of the battle, the call of pharmacists is more than ever.” Meredith Lauderdale, Executive Vice President of Joint Drug Sales and Service. “Our alliance with FDS Amplicare will provide business intelligence and analytical tools that will enable our members to enhance the health of pharmacies and patients almost overnight.”
Common drug analysis includes other key features that enable pharmacies to:
- Get daily, weekly and monthly reports on key indicators, such as missing supplements, missing patients, uncertain or pending claims
- Automate basic reporting to increase accountability for patient calls, verify expenses and catch billing errors
- Track patients’ supplementary activities and prioritize outreach based on factors such as treatment gaps and supplementary margins
- Improve compliance scores by zeroing out the best patients who can have an immediate impact on the overall score
To learn more about FDS Amplicare, please visit www.fdsrx.com or www.Amplicare.com.
About FDS Amplicare:
FDS Amplicare enhances the health of pharmacies and their patients. By providing innovative software products and services, we promote the development of a new era of clinically focused pharmacies, enabling our customers to provide comprehensive pharmacy and clinical care services to their communities.
About mutual aid drugs
Mutual Drug is a member network composed of more than 500 independent pharmacies, which can provide innovative pharmacy solutions. Mutual Drug has contributed to the success of its members by leveraging the collaborative network of pharmacies, powerful group purchases, obtaining products and supplies, legislative publicity, and a full set of business support services.
Media contact:
King Worth, Amendola Communications, kwarth@acmarketingpr.com
View original content to download multimedia:http://www.prnewswire.com/news-releases/fds-amplicare-and-mutual-drug-offers-analytics-solution-to-member-pharmacies-301292384.html
Source: FDS Amplicare
[ad_2]
Source link